GlassScriptPhysician profile
Brendon Pardington
NPI 1992835748
$761.22
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $321 · 2023: $237 · 2024: $203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $440.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $440.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $177.44 | 2023-2024 | Quviviq |
| Abbvie INC. | $143.18 | 2022-2024 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $107.99 | 2022-2023 | |
| Alkermes, INC. | $74.46 | 2022-2024 | Aristada, Lybalvi |
| Otsuka America Pharmaceutical, INC. | $68.77 | 2022-2024 | Rexulti, Abilify Maintena |
| Neurocrine Biosciences, INC. | $55.87 | 2022-2023 | Ingrezza |
| Sunovion Pharmaceuticals INC. | $37.64 | 2022 | |
| Janssen Pharmaceuticals, INC | $34.57 | 2023 | Spravato |
| Lundbeck LLC | $27.83 | 2022 | |
| Ironshore Pharmaceuticals INC. | $20.19 | 2022 | |
| Supernus Pharmaceuticals, INC. | $13.28 | 2024 | Qelbree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brendon Pardington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.